News, features, and commentary about cancer-related issues
— News, features, and commentary about cancer-related issues
July 10, 2026
• 2 min read
A study of national insurance claims data showed that a fourth of patients with newly diagnosed cancers had a recent emergency department (ED) visit that resulted in nonspecific findings. (Trilliant Health)
Accord BioPharma announced FDA approval of pegfilgrastim-pccg (Ennumo) for prevention of neutropenia caused by cancer treatment, the eighth biosimilar to reference pegfilgrastim (Neulasta).
News, features, and commentary about cancer-related issues
Want to Stay Current on Latest in Cancer Prevention and Treatment? Free Service from NCCN Can Help
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta
PHOENIX — Mirvetuximab, an antibody drug conjugate for the treatment of certain types of cancer, can lead to adverse ocular…
Stay up to date with notifications from The IndependentNotifications can be managed in browser…
